Nova Leap Health Corp (TSE:NLH)
:NLH
Want to see TSE:NLH full AI Analyst Report?
Top Page
Nova Leap Health
(NLH)
Select Model
Select Model
Rating:67Neutral
Price Target:
C$0.46
▲(62.86% Upside)
Action:Reiterated
Date:05/14/26
The score is driven primarily by improving scale and positive/free cash flow alongside a conservatively levered balance sheet, tempered by inconsistent profitability and weak recent ROE. Technicals are supportive with a strong trend above major moving averages, while valuation is only moderate given a ~17.2 P/E and no dividend yield data.
Positive Factors
Revenue scale growth
Material year-over-year TTM revenue growth demonstrates expanding service volume and successful footprint scaling. Persistent top-line growth supports fixed-cost absorption, strengthens local market position and payor negotiating leverage, and underpins longer-term organic and acquisition-driven expansion.
Negative Factors
Inconsistent profitability & margin pressure
Earnings volatility and compressed operating margins indicate limited pricing power or rising operating costs. Persistent margin pressure reduces retained earnings available for reinvestment, complicates forecasting, and raises the risk that growth fails to translate into durable shareholder returns over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue scale growth
Material year-over-year TTM revenue growth demonstrates expanding service volume and successful footprint scaling. Persistent top-line growth supports fixed-cost absorption, strengthens local market position and payor negotiating leverage, and underpins longer-term organic and acquisition-driven expansion.
Read all positive factors
Nova Leap Health (NLH) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$34.05M
Dividend YieldN/A
Average Volume (3M)21.45K
Price to Earnings (P/E)17.2
Beta (1Y)0.45
Revenue Growth21.03%
EPS Growth-75.00%
CountryCA
Employees541
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding87,314,255
10 Day Avg. Volume17,344
30 Day Avg. Volume21,452
Financial Highlights & Ratios
PEG Ratio0.81
Price to Book (P/B)0.94
Price to Sales (P/S)0.56
P/FCF Ratio12.58
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nova Leap Health Business Overview & Revenue Model
Company Description
Nova Leap Health Corp. provides home and home health care services in the United States and Canada. Its services include dementia care, companionship, personal and respite care, cooking and meal preparation, bathing, dressing, grooming, housekeepi...
How the Company Makes Money
NLH makes money primarily by delivering home care visits and caregiver hours through its operating agencies and billing clients (or payors acting on the client’s behalf) for those services. Its key revenue stream is service revenue generated from ...
Nova Leap Health Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
74
Positive
Cash Flow
68
Positive
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 32.10M | 32.02M | 25.76M | 26.18M | 28.21M | 21.28M |
| Gross Profit | 12.65M | 11.85M | 9.89M | 9.77M | 9.98M | 7.21M |
| EBITDA | 1.54M | 1.97M | 2.50M | 994.47K | 420.35K | 4.76M |
| Net Income | 206.88K | -193.19K | 1.38M | -1.05M | -835.75K | 1.76M |
Balance Sheet | ||||||
| Total Assets | 23.45M | 23.44M | 22.39M | 20.90M | 23.95M | 26.77M |
| Cash, Cash Equivalents and Short-Term Investments | 1.61M | 1.49M | 1.40M | 894.76K | 1.27M | 1.73M |
| Total Debt | 2.83M | 2.93M | 2.53M | 1.40M | 3.97M | 6.20M |
| Total Liabilities | 4.36M | 4.43M | 4.14M | 2.70M | 5.27M | 8.29M |
| Stockholders Equity | 19.10M | 19.01M | 18.25M | 18.20M | 18.68M | 18.48M |
Cash Flow | ||||||
| Free Cash Flow | 1.44M | 1.42M | 1.36M | 2.13M | 949.49K | 2.18M |
| Operating Cash Flow | 1.68M | 1.42M | 1.39M | 2.15M | 1.02M | 2.18M |
| Investing Cash Flow | -279.20K | -1.26M | -1.59M | -23.13K | -56.24K | -7.40M |
| Financing Cash Flow | -1.16M | -86.91K | 729.78K | -2.52M | -1.41M | 4.33M |
Nova Leap Health Technical Analysis
Positive
0.28
Price Trends
0.36
Positive
0.33
Positive
0.32
Positive
Market Momentum
0.01
Negative
54.38
Neutral
66.67
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:NLH, the sentiment is Positive. The current price of 0.28 is below the 20-day moving average (MA) of 0.38, below the 50-day MA of 0.36, and below the 200-day MA of 0.32, indicating a bullish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 54.38 is Neutral, neither overbought nor oversold. The STOCH value of 66.67 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSE:NLH.
Nova Leap Health Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | C$304.76M | 6.82 | 27.57% | 2.35% | -0.15% | -50.57% | |
69 Neutral | C$3.25B | 15.41 | 45.35% | 2.28% | 18.81% | 50.80% | |
67 Neutral | C$34.05M | 17.20 | 4.10% | ― | 21.03% | -75.00% | |
64 Neutral | C$225.68M | 50.45 | 27.47% | 1.03% | 2.20% | ― | |
62 Neutral | C$2.21B | 32.90 | 6.44% | 4.47% | 16.69% | 11.12% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
46 Neutral | C$832.71K | -0.14 | 202.02% | ― | -42.83% | -8.34% |
* General Sector Average
TSE:NLH
Nova Leap Health
0.39
0.12
44.44%
TSE:CRRX
CareRx
3.59
0.82
29.42%
TSE:EXE
Extendicare
34.30
20.31
145.14%
TSE:SIA
Sienna Senior Living
22.27
5.19
30.40%
TSE:DR
Medical Facilities
17.48
2.44
16.18%
TSE:PHA
Premier Health of America Inc
0.02
-0.07
-82.35%
Nova Leap Health Corporate Events
Business Operations and StrategyFinancial Disclosures
Nova Leap Posts Record 2025 Results as It Expands Into Broader Community-Based Care
Positive
Mar 6, 2026
Nova Leap Health reported its strongest year on record in 2025, with consolidated revenue rising 22.2% to $31.5 million and adjusted EBITDA up 31.0% to $2.05 million, achieved while keeping leverage low and without issuing new equity since 2022. M...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.